Capital Markets increased its price target on Perspective Therapeutics Inc (NYSE:CATX) shares to $20.00, up from the previous $15.00, while maintaining a Buy rating on the stock. The $259.2 million ...

In the closing of the recent trading day, Lucid Group (LCID) stood at $2.75, denoting a -1.43% change from the preceding trading day.

Manufacturing in EV's and Batteries on the Rise to Meet Global Growth Demands January 27, 2025 (Investorideas Newswire) Invest ...

A big selloff in tech stocks on Monday was dragging down a host of shares, including electric-vehicle makers such as Tesla.

Lucid Motors exceeded Q4 2024 delivery expectations but faces challenges in 2025 due to the removal of the EV tax credit.

Ballentine Partners LLC reduced its position in shares of Lucid Group, Inc. (NASDAQ:LCID – Free Report) by 44.9% in the ...

PAVMed Inc., a medical device company with a market capitalization of just $6.86 million, is currently under scrutiny from ...

The stock market offers several opportunities to turn modest investments into fortunes, provided investors make strategic ...

It's been a bumpy ride for many electric vehicle (EV) stocks over the past few years, and both Rivian Automotive (NASDAQ: ...

Get ready for Tesla's Q4 earnings report on January 29. Analysts expect revenue of $27.1 billion and $0.77 earnings per share ...

Shares of the electric vehicle start-up Lucid Group (NASDAQ: LCID) fell 9.4% this week, according to data from S&P Global ...

Lucid stock is less than 5% of what it was at its peak. The primary concern about the struggling EV maker is whether it can ...